1608 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Recruiting Sequential Intranodal Immunotherapy (SIIT) Combined With Anti-PD1 (Pembrolizumab) in Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Radiation: Radiotherapy;   Biological: Rituximab;   Biological: Autologous dendritic cells;   Biological: GM-CSF;   Biological: Pembrolizumab
22 Not yet recruiting Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma
Conditions: Peripheral T-cell Lymphoma;   Cutaneous T-cell Lymphoma
Intervention: Drug: E7777
23 Not yet recruiting Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors With Lymphedema and Fibrosis
Conditions: Cancer Survivor;   Head and Neck Carcinoma;   Lymphedema-Related Fibrosis Adverse Event;   No Evidence of Disease
Interventions: Procedure: Medical Examination;   Other: Questionnaire Administration;   Procedure: Shear Wave Elastography
24 Not yet recruiting Study of the Safety and Efficacy of MIW815 (ADU-S100) in Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Condition: Advanced/Metastatic Solid Tumors or Lymphomas
Intervention: Drug: ADU-S100
25 Recruiting Study to Evaluate the Efficacy and Safety of CUDC-907 With and Without Rituximab in Patients With RR MYC-Altered DLBCL
Condition: Relapsed and/or Refractory Diffuse Large B-cell Lymphoma
Interventions: Drug: CUDC-907;   Drug: Rituximab
26 Recruiting A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia
Condition: Leukemia, B-Cell
Intervention: Drug: anti-CD19-CAR-T cells
27 Not yet recruiting Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Cytarabine;   Drug: Vinblastine/prednisone
28 Not yet recruiting Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
Condition: Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma
Interventions: Drug: Ibrutinib;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: vincristine;   Drug: Prednisolone
29 Recruiting ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
Condition: Acute Lymphoblastic Leukemia
Interventions: Genetic: Pharmacogenomics;   Other: Busulfan plasma level measurements
30 Recruiting PQR309 in Patients With Relapsed or Refractory Primary CNS Lymphoma
Condition: Primary Central Nervous System Lymphoma
Intervention: Drug: PQR309
31 Not yet recruiting Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: ADCT-402
32 Not yet recruiting Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
Condition: Non-Hodgkin Lymphoma
Intervention: Drug: ADCT-402
33 Not yet recruiting Search Elevated Serum Alkaline Phosphatase as a Marker of Prenatal Intervillositis Chronic Histiocytic
Condition: Chronic Histiocytosis
Intervention:
34 Recruiting Phase II Trial GA101 Inbrutinib B CLL
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Interventions: Drug: GA101;   Drug: Ibrutinib;   Drug: Cyclophosphamide;   Drug: Fludarabine
35 Not yet recruiting Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Condition: Hodgkin Lymphoma
Interventions: Biological: AFM13;   Biological: Pembrolizumab
36 Not yet recruiting Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Intervention:
37 Not yet recruiting Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant
Conditions: Chronic Lymphocytic Leukemia;   Non-Hodgkin Lymphoma;   Prolymphocytic Leukemia;   Recurrent Chronic Lymphocytic Leukemia;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Small Lymphocytic Lymphoma
Interventions: Drug: Ibrutinib;   Drug: Idelalisib
38 Recruiting Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced PCD
Condition: Lymphedema
Intervention: Device: Advanced Pneumatic Compression Device
39 Recruiting Study of FF-10502-01 in Patients With Advanced Solid Tumors and Lymphomas
Conditions: Solid Tumors;   Lymphomas
Intervention: Drug: FF-10502-01
40 Not yet recruiting HD21 for Advanced Stages
Condition: Classical Hodgkin Lymphoma
Interventions: Drug: Bleomycin;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Procarbazine;   Drug: Prednisone;   Drug: Brentuximab Vedotin;   Drug: Dacarbazine;   Drug: Dexamethasone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years